International Union of Societies for Biomaterials Science and Engineering (IUS-BSE)
The International Union of Societies for Biomaterials Science and Engineering represents the international biomaterials community and is composed of two members from each of the consituent societies. The two current CBS members can be found here.
The IUS-BSE meets every four years at the World Biomaterials Congress, and otherwise annually at the Society for Biomaterials (U.S.) conference. It also works informally between meetings. To maintain continuity between World Congresses, the committee is chaired by the members from one society on a 4-year rotation. Further, each society is asked to keep its IUS-BSE representation constant during that time.
You may visit the IUS-BSE's website here.
Here is the organizational membership of the current IUS-BSE. For more information on each member society, visit their homepage:
- The Society for Biomaterials and Artificial Organs India
- Latin American Society for Biomaterials and Artificial Organs (SLABO)
- Chinese Taipei Society for Biomaterials and Controlled Release
World Biomaterials Congress
The principal duty of the IUS-BSE is the organization of a World Biomaterials Congress once every four years. The previous world congresses and those currently planned are:
- Vienna, Austria (1980)
- Washington, U.S.A. (1984)
- Kyoto, Japan (1988)
- Berlin, Germany (1992)
- Toronto, Canada (1996)
- Hawaii, U.S.A (2000)
- Sydney, Australia (2004)
- Amsterdam, the Netherlands (2008)
- Chengdu, China (2012)
- Montréal, Canada (2016)
- Glasgow, Scotland (2020)
- Daegu, South Korea (2024)
For more information on the World Biomaterials Congresses, see the WBC site at www.worldbiomaterials.org.
Fellows in Biomaterials Science and Engineering
The IUS-BSE is also responsible for naming the recipients of the title of Fellow of Biomaterials Science and Engineering (FBSE). You can learn more about this honour and the current Canadian recipients here.
Biomaterial Highlight Of The Month
PAMAM dendrimer based formulation of haloperidol for brain targeting via intranasal delivery
Read More
